Índia - anglès - Central Drugs Standard Control Organization

neiss - clindamycin,nicotinamide - oint - 1,4;% - 10g

Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

kotra pharma (m) sdn. bhd. - ascorbic acid; vitamin a; calcium pantothenate; copper sulphate; folic acid; inositol; magnesium sulphate; zinc sulphate; ferrous fumarate; choline bitartrate; cyanocobalamin; manganese sulphate; pyridoxine hcl/vitamin b6; riboflavine; thiamine hydrochloride/vit b1; vit e,dl-alpha tocopheryl acetate; vitamin d 3; potassium sulphate; nicotinamide; calcium carbonate; pottasium iodide; ginseng dry extract -

Uganda - anglès - National Drug Authority

klm laboratories pvt. ltd. - clindamycin phosphate + nicotinamide - topical external gels and sols - 1.0 %w/w + 4.0%w/w

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - lincomycin hydrochloride monohydrate, quantity: 340.26 mg/ml (equivalent: lincomycin, qty 300 mg/ml) - injection, solution - excipient ingredients: benzyl alcohol; water for injections - indications as at 22 september 1994: lincocin is indicated in the treatment of serious infections due to susceptible strains of gram positive aerobes such as streptococci, pneumococci and staphylococci. its use should be reserved for penicillin allergic patients or other patients for whom, in the judgement of the physician, a penicillin is inappropriate. because of the risk of colitis (see precautions), before selecting lincomycin the physician should consider the nature of infection and the suitability of less toxic alternatives (e.g.erythromycin). lincocin has been demonstrated to be effective in the treatment of staphylococcal infections resistant to other antibiotics and susceptible to lincomycin. staphylococcal strains resistant to lincocin have been recovered; culture and susceptibility studies should be done in conjunction with lincocin therapy. in the case of macrolides, partial but not complete cross resistance may occur. the drug may be administered concomitantly with other antimicrobial agents with

Índia - anglès - Central Drugs Standard Control Organization

sifam ph. - clindamycin phosphate,nicotinamide - gel - 1,4;% - 20g

Índia - anglès - Central Drugs Standard Control Organization

med manor - clindamycin phosphate,nicotinamide - gel - 1,4;%;w/w - 10 g

Índia - anglès - Central Drugs Standard Control Organization

candor bio. - clindamycin phosphate,nicotinamide - oint - 1,4;% - 10/20;g

Índia - anglès - Central Drugs Standard Control Organization

lifestar - clindamycin phosphate,nicotinamide - gel - 1%,4%(+aloe,allantoin) - 15g

Índia - anglès - Central Drugs Standard Control Organization

adventus - clindamycin phosphate,nicotinamide - gel - in aloe-allantoin gel base - 20g

Índia - anglès - Central Drugs Standard Control Organization

aldok ph. - clindamycin phosphate,nicotinamide - gel - 1,4;%